These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37918791)

  • 1. Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease.
    Cavalier E; Farré-Segura J; Lukas P; Gendebien AS; Peeters S; Massonnet P; Le Goff C; Bouquegneau A; Souberbielle JC; Delatour V; Delanaye P
    Kidney Int; 2024 Feb; 105(2):338-346. PubMed ID: 37918791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of PTH measurement by LC-MS/MS: a promising solution for interassay variability.
    Nakagawa Y; Komaba H
    Kidney Int; 2024 Feb; 105(2):244-247. PubMed ID: 38245214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of an LC-MS/MS Method Using Solid-Phase Extraction for the Quantification of 1-84 Parathyroid Hormone: Toward a Candidate Reference Measurement Procedure.
    Farré-Segura J; Le Goff C; Lukas P; Cobraiville G; Fillet M; Servais AC; Delanaye P; Cavalier E
    Clin Chem; 2022 Nov; 68(11):1399-1409. PubMed ID: 36056745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone measurement in chronic kidney disease: Impact of inter-method variability on mineral bone disease assessment.
    White CA; Sarabia S; Collier CP; McCudden C; Holden RM
    Clin Biochem; 2021 Aug; 94():62-66. PubMed ID: 33895125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of parathyroid hormone: from radioimmunoassay to LCMS/MS.
    Cavalier E
    Clin Chem Lab Med; 2023 Apr; 61(5):946-953. PubMed ID: 36640443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry.
    Kumar V; Barnidge DR; Chen LS; Twentyman JM; Cradic KW; Grebe SK; Singh RJ
    Clin Chem; 2010 Feb; 56(2):306-13. PubMed ID: 20007860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Resolution Mass Spectrometry for the Measurement of PTH and PTH Fragments: Insights into PTH Physiology and Bioactivity.
    Ulmer CZ; Kritmetapak K; Singh RJ; Vesper HW; Kumar R
    J Am Soc Nephrol; 2022 Aug; 33(8):1448-1458. PubMed ID: 35396262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical Governance Issue of Parathyroid Hormone Assays and its Selection in the Management of Chronic Kidney Disease Mineral and Bone Disorders.
    Kakuta T; Ishida M; Fukagawa M
    Ther Apher Dial; 2018 Jun; 22(3):220-228. PubMed ID: 29781225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-method variability in PTH measurement: implication for the care of CKD patients.
    Souberbielle JC; Boutten A; Carlier MC; Chevenne D; Coumaros G; Lawson-Body E; Massart C; Monge M; Myara J; Parent X; Plouvier E; Houillier P
    Kidney Int; 2006 Jul; 70(2):345-50. PubMed ID: 16788691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid Hormone Fragments: New Targets for the Diagnosis and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.
    Chen H; Han X; Cui Y; Ye Y; Purrunsing Y; Wang N
    Biomed Res Int; 2018; 2018():9619253. PubMed ID: 30627584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTH determination in hemodialyzed patients-A laboratory perspective.
    Cavalier E; Souberbielle JC; Delanaye P
    Semin Dial; 2019 Nov; 32(6):490-492. PubMed ID: 31631422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications.
    Kritmetapak K; Pongchaiyakul C
    Int J Nephrol; 2019; 2019():5496710. PubMed ID: 31637056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of iPTH values in serum and plasma samples depending on the time and temperature in patients with chronic kidney disease.
    Bencova V; Maris K; Spustova V; Gazovic V; Straussova Z; Cernohorska B; Nemethova D
    Bratisl Lek Listy; 2014; 115(7):439-41. PubMed ID: 25077368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS candidate reference methods for the harmonisation of parathyroid hormone (PTH) measurement: a review of recent developments and future considerations.
    Couchman L; Taylor DR; Krastins B; Lopez MF; Moniz CF
    Clin Chem Lab Med; 2014 Sep; 52(9):1251-63. PubMed ID: 24762644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CKD-MBD Syndrome: Hysteresis in PTH Involvement and PTH Administration for Its Management.
    Pazianas M; Miller PD
    J Bone Miner Res; 2020 Dec; 35(12):2313-2317. PubMed ID: 32780482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The path to the standardization of PTH: Is this a realistic possibility? a position paper of the IFCC C-BM.
    Cavalier E; Vasikaran S; Bhattoa HP; Heijboer AC; Makris K; Ulmer CZ
    Clin Chim Acta; 2021 Apr; 515():44-51. PubMed ID: 33412144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of Parathyroid Hormone in Serum or Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
    Ketha H; Singh RJ
    Methods Mol Biol; 2016; 1378():211-7. PubMed ID: 26602132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy.
    Bekő G; Butz H; Berta K; Tislér A; Olajos F; Vásárhelyi B; Patócs A
    Clin Chem Lab Med; 2013 Jun; 51(6):1251-6. PubMed ID: 23241601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis Patients.
    Karaboyas A; Muenz D; Fuller DS; Desai P; Lin TC; Robinson BM; Rossetti S; Pisoni RL
    Am J Kidney Dis; 2022 Mar; 79(3):362-373. PubMed ID: 34273436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
    Reichel H; Esser A; Roth HJ; Schmidt-Gayk H
    Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.